Michael John Dickinson

49PUBLICATIONS
271CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Separation technologiesOncology and carcinogenesis not elsewhere classifiedHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Aug 17, 2026
Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: Phase 1b dose-escalation study.

|Aug 14, 2026
Shortened axi-cel manufacturing drives rapid in vivo expansion and shifts the acute toxicity profile in R/R LBCL.

|Jul 16, 2026
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial.

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|May 05, 2026
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

|Apr 23, 2026
Glofitamab monotherapy in patients with Richter transformation: safety and efficacy from a phase 1 study.

Pageof 9

Frequent Collaborators

9 joint publications

Chan Y Cheah

9 joint publications

Nada Hamad

8 joint publications

Matthew Ku

6 joint publications

Adrian Minson